In contrast to the harmful effects of USP22 in late phases of NAFLD, another study implied that USP22 attenuates lipid deposition in the liver by modifying mitochondrial respiration. The gene discussed is USP22; the disease is metabolic dysfunction-associated steatotic liver disease.